Abstract
The dipeptidylpeptidase IV is an activation marker on T B and NK cells Specific inhibitors of DP IV suppress DNA synthesis, as well as cytokine protein production Here, we describe for the first time the quantitative changes of mRNA expression of IFN-γ, IL-2, IL-12 and DP IV after inhibition of DP IV Due to the stimulation of human peripheral blood mononuclear cells (PBMC) with pokeweedmitogen (PWM) both cytokine as well as DP IV mRNA expression is increased significantly Treatmentwith DP IV inhibitor suppresses dose-dependentlythese changes Importantly, mRNA expression of DP IV itself was inhibited The presented data are fully compatible with our hypothesis that inhibition of DP IV leads to cell cycle arrest in late Gl due to enhanced IGI-β1 expression
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Referemces
Abbott, C.A., et al., 1994, Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene. Immunogenetics 40: 331–338.
Ansorge, S., et al., 1991, Membrane-bound peptidases of lymphocytes: functional implications. Biomed.. Biochim. Acta 50: 799–807.
Boyum, A., 1968, Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at l g. Scand.. J. Clin. Lab. Invest. Suppl. 97: 77–89.
Bühling, F., et al., 1995, Functional role of CD26 on human B lymphocytes. Immunol. Lett. 45: 47–51.
Bühling, F., et al., 1994, Expression and functional role of dipeptidyl peptidase IV (CD26) on human natural killer cells. Nat. Immun. 13: 270–279.
Hegen, M., 1997, In Leukocyte Typing VI (T. Kishimoto, and H. Kikutani, eds), Garland Publishing Inc. pp. 478–481.
Julius, M.H., et al., 1973, A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3: 645–649.
Kähne, T., et al., 1999, Dipeptidyl peptidase IV: A cell surface peptidase involved in regulating T cell growth. Int. J. Mol. Med. 4: 3–15.
Rahfeld, J., et al., 1991, Extended investigation of the substrate specificity of dipeptidyl peptidase IV from pig kidney. Biol. Chem. Hoppe Seyler 372: 313–318.
Reinhold, D., et al., 1997a, Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-beta 1 in PWM-stimulated PBMC and T cells. Immunology 91: 354–360.
Reinhold, D., et al., 1997b, Inhibitors of dipeptidyl peptidase IV (DP IV, CD.26) induces secretion of transforming growth factor-β1 (TGF-β1) in stimulated mouse splenocytes and thymocytes. Immunol. Lett. 58: 29–35.
Schön, E., et al., 1985, The dipeptidyl peptidase IV, a membrane enzyme involved in the proliferation of T lymphocytes. Biomed. Biochem. Acta 44: 9–15.
Ulmer, A.J., et al., 1990, CD26 antigen is a surface dipeptidyl peptidase IV (DPPIV) as characterized by monoclonal antibodies clone TII-19-4-7 and 4EL1C7. Scand J. Immunol. 31: 429–435.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Arndt, M. et al. (2002). Specific Inhibitors of Dipeptidyl Peptidase IV Suppress mRNA Expression of DP IV/CD26 and Cytokines. In: Langner, J., Ansorge, S. (eds) Cellular Peptidases in Immune Functions and Diseases 2. Advances in Experimental Medicine and Biology, vol 477. Springer, Boston, MA. https://doi.org/10.1007/0-306-46826-3_15
Download citation
DOI: https://doi.org/10.1007/0-306-46826-3_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46383-9
Online ISBN: 978-0-306-46826-1
eBook Packages: Springer Book Archive